+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Cathepsin-d activity levels in colorectal-cancer - correlation with cathepsin-B and cathepsin-L and other biological and clinical-parameters

Cathepsin-d activity levels in colorectal-cancer - correlation with cathepsin-B and cathepsin-L and other biological and clinical-parameters

International Journal of Oncology 5(3): 509-515

Cathepsin D, B and L activity levels were determined in colorectal cancer and correlated with a number of biological and clinical parameters. Our studies have evidenced significant higher activity levels of these lysosomal enzymes in tumor cytosol compared to paired normal mucosa as well as an evident increase of tumor specific cathepsin D activity in Dukes' stage A tumors compared to later stages (B, C and D). Furthermore, significant higher cathepsin B and L activity levels were observed in Dukes' stage A compared to Dukes' stage D tumors while significant higher cathepsin B activity levels were observed in tumors less than or equal to 5 cm than in those >5 cm as well as in moderately differentiated tumors (G2) than in well differentiated (G1) ones. No further correlation between tumor specific cathepsin B activity levels and other parameters examined i.e., anatomical site, nodal status, DNA ploidy, and proliferation rate (S-phase fraction) or between tumor specific cathepsin D and L and all these parameters were observed. These results indicate that cathepsin D, B and L may be involved in colorectal tumor progression by acting, probably, at different levels of this process and suggest that the altered tumor specific activity of these proteinases may be of interest as independent, prognostic factor of malignant progression of this neoplastic disease.

Please choose payment method:

(PDF emailed within 0-6 h: $19.90)

Accession: 051972262

Download citation: RISBibTeXText

PMID: 21559606

DOI: 10.3892/ijo.5.3.509

Related references

Cathepsin D content in colorectal cancer:: Correlations with cathepsin D activity and other biological parameters: A preliminary report. Oncology 52(3): 237-242, 1995

Serum cathepsin B levels, urinary excretion of cathepsin B and tissue cathepsin B content in the patients with gastric cancer. Nihon Geka Hokan. Archiv für Japanische Chirurgie 62(5): 217-221, 1993

Serum cathepsin B levels, urinary excretion of cathepsin B and cancer tissue content of cathepsin B in patients with breast cancer. Medical Science Research 22(1): 31-32, 1994

Serum cathepsin-B levels and urinary-excretion of cathepsin-B in the patients with colorectal-cancer - possible indicators for tumor malignancy. International Journal of Oncology 4(1): 151-153, 1994

Cathepsin B, cathepsin H, cathepsin X and cystatin C in sera of patients with early-stage and inflammatory breast cancer. International Journal of Biological Markers 23(3): 161-168, 2008

Cathepsin B, a prognostic indicator in lymph node-negative breast carcinoma patients: comparison with cathepsin D, cathepsin L, and other clinical indicators. Clinical Cancer Research 6(2): 578-584, 2000

Expression, proliferation activity and clinical significance of cathepsin B and cathepsin L in operated lung cancer. Anticancer Research 23(3c): 2767-2772, 2003

Relationship between cathepsin B, cathepsin D expression and biological behaviour in mucinous colorectal carcinoma. Chinese Medical Sciences Journal 19(1): 12, 2004

Cathepsin B in the growth of colorectal cancer: increased activity of cathepsin B in human colorectal cancer. Acta Medica Okayama 50(6): 305-311, 1996

Cathepsin B, L and D activity levels in colorectal cancer Correlation with other prognostic parameter of malignant progression. Proceedings of the American Association for Cancer Research Annual Meeting 35: 69, 1994

Activation of cathepsin B, secreted by a colorectal cancer cell line requires low pH and is mediated by cathepsin D. International Journal of Cancer 67(4): 547-554, 1996

Biological significance and activity control of cathepsin E compared with cathepsin D. Advances in Experimental Medicine and Biology 306: 297-306, 1991

Differential cathepsin responses to inhibitor-induced feedback: E-64 and cystatin C elevate active cathepsin S and suppress active cathepsin L in breast cancer cells. International Journal of Biochemistry and Cell Biology 79: 199-208, 2016

Serum cathepsin B levels and urinary excretion of cathepsin B in the cancer patients with remote metastasis. Cancer Letters 70(1-2): 41-44, 1993

Plasminogen hydrolysis by cathepsin S and identification of derived peptides as selective substrate for cathepsin V and cathepsin L inhibitor. Biological Chemistry 391(5): 561-570, 2010